These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 19438545

  • 1. Coexistence of mucous membrane pemphigoid and connective-tissue disease.
    Malik M, Gürcan HM, Ahmed AR.
    Clin Exp Dermatol; 2010 Mar; 35(2):156-9. PubMed ID: 19438545
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid.
    Sami N, Bhol KC, Razzaque Ahmed A.
    Clin Immunol; 2002 Jan; 102(1):59-67. PubMed ID: 11781068
    [Abstract] [Full Text] [Related]

  • 4. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ, Amin KG.
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [Abstract] [Full Text] [Related]

  • 5. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y, Amin KG, Mohan K, Ahmed AR.
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N, Letko E, Androudi S, Daoud Y, Foster CS, Ahmed AR.
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [Abstract] [Full Text] [Related]

  • 8. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [Abstract] [Full Text] [Related]

  • 9. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
    Segura S, Iranzo P, Martínez-de Pablo I, Mascaró JM, Alsina M, Herrero J, Herrero C.
    J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
    [Abstract] [Full Text] [Related]

  • 10. [Nephropathy in patients with mixed connective tissue disease].
    Yoshida A, Morozumi K, Takeda A, Koyama K.
    Ryumachi; 1994 Dec; 34(6):976-80. PubMed ID: 7863388
    [Abstract] [Full Text] [Related]

  • 11. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
    Canizares MJ, Smith DI, Conners MS, Maverick KJ, Heffernan MP.
    Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
    [Abstract] [Full Text] [Related]

  • 12. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O.
    Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
    [Abstract] [Full Text] [Related]

  • 13. Mucous membrane pemphigoid: nasal and laryngeal manifestations.
    Whiteside OJ, Martinez Devesa P, Ali I, Capper JW.
    J Laryngol Otol; 2003 Nov; 117(11):885-8. PubMed ID: 14670151
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin treatment in laryngeal pemphigoid.
    Gürcan HM, Ahmed AR.
    Clin Exp Dermatol; 2009 Dec; 34(8):884-6. PubMed ID: 19094130
    [Abstract] [Full Text] [Related]

  • 15. [Benign pemphigoid of the mucous membranes: the clinical and histopathological aspects in 20 patients].
    Capecchi M, Ficarra G, Pagni L.
    Minerva Stomatol; 1994 Sep; 43(9):423-8. PubMed ID: 7816017
    [Abstract] [Full Text] [Related]

  • 16. Familial aspects of mixed connective tissue disease (MCTD). I. Occurrence of systemic lupus erythematosus in another member in two families and aggregation of MCTD in another family.
    Ramos-Niembro F, Alarcon-Segovia D.
    J Rheumatol; 1978 Sep; 5(4):433-40. PubMed ID: 310886
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
    Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M.
    Chest; 2006 Jul; 130(1):182-9. PubMed ID: 16840400
    [Abstract] [Full Text] [Related]

  • 18. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study.
    Letko E, Bhol K, Foster SC, Ahmed RA.
    Curr Eye Res; 2000 Aug; 21(2):646-54. PubMed ID: 11148601
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients.
    Rauz S, Maddison PG, Dart JK.
    Ophthalmology; 2005 Jul; 112(7):1268-74. PubMed ID: 15921743
    [Abstract] [Full Text] [Related]

  • 20. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD, Fortuna G, Leuci S, Ruoppo E, Adamo D, Fedele S.
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.